about
Cutaneous manifestations of hepatitis C in the era of new antiviral agentsHepatitis C Therapy in Renal Patients: Who, How, When?Global epidemiology and burden of HCV infection and HCV-related disease.Gastrointestinal aspects of vasculitides.Treatment of primary Sjögren syndrome.The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.Management of Neurologic Manifestations in Patients with Liver Disease.Managing refractory cryoglobulinemic vasculitis: challenges and solutionsPresence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy.Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection.Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab TherapyNew insights into HCV-related rheumatologic disorders: A review.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.HCV Treatments and Their Integration Into Rheumatology.Why do I treat my patients with mild hepatitis C?Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.The impact of antiviral therapy for hepatitis C on the quality of life: a perspective.Resolution of Q Fever-Associated Cryoglobulinemia With Anti-CD20 Monoclonal Antibody Treatment.Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Antivirals.Cryoglobulinaemic glomerulonephritis: artefacts associated with laboratory diagnosis and need for renal biopsy.Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.[Cryoglobulinemic vasculitis].CNS Vasculitis Associated with Waldenström Macroglobulinemia.Hepatitis C Virus-Associated Aortitis Caused by Type I Cryoglobulins.Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?Pigmented purpura and cutaneous vascular occlusion syndromes.Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugsCorrelation of CCR5 and NLRP3 gene polymorphisms with renal damage due to hepatitis C virus-related cryoglobulinemia
P2860
Q26773669-D17F38EA-E7E0-4244-953E-C61CEAF5C92FQ28077130-8A12B4B6-C03D-4642-8FDA-734B76304474Q30240220-4144740F-9AFB-431A-A391-559741A28E42Q30240787-B08ACA9A-B234-4501-91D1-CA2CB92E35A5Q30249011-8C76A090-5A79-409B-9859-1A44AA03481FQ30251847-7373A508-1CB3-4053-85A2-4652335EC350Q31108752-EDB25B79-D34F-4139-A1F5-6A565F963DC9Q33673888-A4C19F9B-C911-4EA4-8806-BC06EC0422A2Q36358880-4781D475-5DB7-4B11-80FC-12CE0EB31167Q36453659-4A91C15F-7798-4418-9B6C-DC2FD0EFE43AQ36949060-00E27874-64E6-4C23-9443-D1AF72F48868Q37610871-BB953CF5-7581-4C40-92A0-CC7C9069783DQ37685491-515197B8-B067-438F-957A-6AE2D39D52D3Q38538199-22F64544-52D8-485D-8410-4F16D308F79CQ38685564-6A02C091-433C-48C9-8302-6915AC5B270BQ38806948-0BB49F0D-132E-483F-852C-190E73CB85E7Q39067380-C519B179-00B9-45F6-B73A-00B6496B329CQ40068762-C180C781-481E-479E-9D70-D88C7839AE03Q40098395-27C16D17-2CB1-4690-87D0-B79DE97DE1F8Q40171525-B8B003A0-924B-413A-B984-C4FF007B7480Q40201639-314B8082-3587-431C-85D1-DEC6B0A3DE86Q40362365-F54D1600-0F7B-49F5-BC3C-93D419C23C50Q40733045-B166BC1F-8E64-4FD4-9177-372C50EFFC97Q41581165-66FFB98F-EC55-4ACC-A87F-C97C912915F4Q44034328-08B21CE4-BFCF-4AED-A860-9D480A7F2CDFQ47171530-5E78FD8B-495E-401B-8BA4-2280C9D6575BQ47298278-E88CCFBC-D3A9-4B26-8F22-A1B2BA4375DCQ47800187-C125CEB5-AFD3-46CD-B846-E43670DD702CQ55287203-88968853-C87F-44B4-AB8D-3A683D6C7432Q58733026-C5EE1CA7-81AB-4FFD-B129-C418904F774BQ58804680-CD22606B-B938-465C-A17A-7C3C48538858
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cryoglobulinemia Vasculitis.
@ast
Cryoglobulinemia Vasculitis.
@en
Cryoglobulinemia Vasculitis.
@nl
type
label
Cryoglobulinemia Vasculitis.
@ast
Cryoglobulinemia Vasculitis.
@en
Cryoglobulinemia Vasculitis.
@nl
prefLabel
Cryoglobulinemia Vasculitis.
@ast
Cryoglobulinemia Vasculitis.
@en
Cryoglobulinemia Vasculitis.
@nl
P2093
P1476
Cryoglobulinemia Vasculitis.
@en
P2093
Cloe Comarmond
Fanny Domont
P304
P356
10.1016/J.AMJMED.2015.02.017
P407
P577
2015-03-30T00:00:00Z